[ad_1]
ZoomInfo Technologies Inc. on Monday cut its full-year forecast and announced changes to its board and its chief financial officer roles.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...